PTPN22 and myasthenia gravis: Replication in an Italian population and meta-analysis of literature data

Neuromuscular Disorders

Volumn 22, Issue 2, 2012, Pages 131-138

  Provenzano, Carlo ^a   Ricciardi, Roberta ^b   Scuderi, Flavia ^a   Maiuri, Maria Teresa ^a   Maestri, Michelangelo ^b   La Carpia, Francesca ^a   Sferrazza, Antonella ^a   Marino, Mariapaola ^a   Leone, Lucia ^a   Lucchi, Marco ^b   Mussi, Alfredo ^b   Zollino, Marcella ^a   Evoli, Amelia ^a   Bartoccioni, Emanuela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Acetylcholine receptor; Autoimmunity; Ecogenetics; Muscle specific kinase; Polymorphism

Indexed keywords

AUTOANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; ITALY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; PRIORITY JOURNAL; PTPN22 GENE; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; THYMUS DISEASE;

ADULT; AUTOANTIBODIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MYASTHENIA GRAVIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 84856348555     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.09.003     Document Type: Article

References (45)

1. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009, 8:475-490.
2. Gregersen P.K., Behrens T.W. Genetics of autoimmune diseases-disorders of immune homeostasis. Nat Rev Genet 2006, 7:917-928.
3. Palmisani M.T., Evoli A., Batocchi A.P., Bartoccioni E., Tonali P. Myasthenia gravis and associated autoimmune diseases. Muscle Nerve 1994, 17:1234-1235.
4. Giraud M., Vandiedonck C., Garchon H.J. Genetic Factors in Autoimmune Myasthenia Gravis. Ann NY Acad Sci 2008, 1132:180-192.
5. Begovich A.B., Carlton V.E., Honigberg L.A., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337.
6. Vang T., Congia M., Macis M.D., et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005, 37:1317-1319.
7. Bottini N., Musumeci L., Alonso A., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338.
8. Fiorillo E., Orrú V., Stanford S.M., et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem 2010, 285:26506-26518.
9. Lee Y.H., Rho Y.H., Choi S.J., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 2007, 46:49-56.
10. Gregersen P.K., Lee H.S., Batliwalla F., Begovich A.B. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006, 18:214-223.
11. Vandiedonck C., Capdevielle C., Giraud M., et al. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 2006, 59:404-407.
12. Lefvert A.K., Zhao Y., Ramanujam R., Yu S., Pirskanen R., Hammarström L. PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis. J Neuroimmunol 2008, 197:110-113.
13. Chuang W.Y., Ströbel P., Belharazem D., et al. The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis. Genes Immun 2009, 10:667-672.
14. Greve B., Hoffmann P., Illes Z., et al. The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis. Hum Immunol 2009, 70:540-542.
15. Kawasaki E., Awata T., Ikegami H., et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 2006, 140:586-593.
16. Qu H., Tessier M.C., Hudson T.J., Polychronakos C. Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study. J Med Genet 2005, 42:266-270.
17. Carlton V.E., Hu X., Chokkalingam A.P., et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005, 77:567-581.
18. Onengut-Gumuscu S., Buckner J.H., Concannon P. A haplotype-based analysis of the PTPN22 locus in type 1 diabetes. Diabetes 2006, 55:2883-2889.
19. Orrú V., Tsai S.J., Rueda B., et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 2009, 18:569-579.
20. Rodríguez-Rodríguez L., Taib W.R., Topless R., et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in caucasian case-control samples. Arthritis Rheum 2011, 63:365-372.
21. Gaunt T.R., Rodriguez S., Day I.N.M. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinf 2007, 8:428.
22. Zoledziewska M., Perra C., Orru' V., et al. Further evidence of a primary, causal association of the PTPN22 620W variant with Type 1 diabetes. Diabetes 2008, 57:229-234.
23. Saccucci P., Del Duca E., Rapini N., et al. Association between PTPN22 C1858T and type 1 diabetes: a replication in continental Italy. Tissue Antigens 2008, 71:234-237.
24. Bafunno V., Santacroce R., Chetta M., et al. Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A. Haemophilia 2010, 16:469-473.
25. Petrone A., Suraci C., Capizzi M., et al. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 2008, 31:534-538.
26. Kokkonen H., Johansson M., Innala L., Jidell E. Rantapää-Dahlqvist S.The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 2007, 9:R56.
27. Mahdi H., Fisher B., Källberg H., et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009, 41:1319-1324.
28. Gourh P., Tan F.K., Assassi S., et al. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum 2006, 54:3945-3953.
29. Sokal R.R., Harding R.M., Oden N. Spatial Patterns of Human Gene Frequencies in Europe. Am J Phys Anthropol 1989, 80:267-294.
30. Barbujani G., Sokal R.R. Genetic Population Structure of Italy. I. Geographic Patterns of Gene Frequencies. Hum Biol 1991, 63:253-272.
31. Novelletto A. Y chromosome variation in Europe: Continental and local processes in the formation of the extant gene pool. Ann Hum Biol 2007, 34:139-172.
32. Lao O., Lu T.T., Nothnagel M., et al. Correlation between genetic and geographic structure in Europe. Curr Biol 2008, 18:1241-1248.
33. Novembre J., Johnson T., Bryc K., et al. Genes mirror geography within Europe. Nature 2008, 456:98-101.
34. Nelis M., Esko T., Magi R., et al. Genetic structure of Europeans: a view from the North-East. PLoS ONE 2009, 4:e5472.
35. Campbell C.D., Ogburn E.L., Lunetta K.L., et al. Demonstrating stratification in a European American population. Nat Genet 2005, 37:868-872.
36. Sahin N., Gunduz F., Inanc N., Direskeneli H., Saruhan-Direskeneli G. No association of PTPN22 gene polymorphism with rheumatoid arthritis in Turkey. Rheumatol Int 2009, 30:81-83.
37. Chabchoub G., Petit Teixiera E., Maalej A., et al. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann Hum Biol 2009, 36:342-349.
38. Sfar I., Dhaouadi T., Habibi I., et al. Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis. Arch Inst Pasteur Tunis 2009, 86:51-62.
39. Alkhateeb A., Qarqaz F., Al-Sabah J., Al Rashaideh T. Clinical characteristics and PTPN22 1858C/T variant analysis in jordanian arab vitiligo patients. Mol Diagn Ther 2010, 14:179-184.
40. Zervou M.I., Castro-Giner F., Sidiropoulos P., Boumpas D.T., Tosca A.D., Krueger-Krasagakis S. The protein tyrosine phosphatase, non-receptor type 22 R620W polymorphism does not confer susceptibility to psoriasis in the genetic homogeneous population of Crete. Genet Test Mol Biomarkers 2010, 14:107-111.
41. Ballerini C., Rosati E., Salvetti M., et al. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neurosci Lett 2002, 328:325-327.
42. Vorechovsky I., Kralovicova J., Tchilian E., et al. Does 77CG in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?. Nat Genet 2001, 29:22-23.
43. Miterski B., Sindern E., Haupts M., Schimrigk S., Epplen J.T. PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients. BMC Med Genet 2002, 3:3.
44. Nicholas R.S., Partridge J., Donn R.P., Hawkins C., Boggild M.D. The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom. J Neurol Neurosurg Psychiatry 2003, 74:944-945.
45. Romanos J., Barisani D., Trynka G., Zhernakova A., Bardella M.T., Wijmenga C. Six new coeliac disease loci replicated in an Italian population confirm association with coeliac disease. J Med Genet 2009, 46:60-63.